In Vivo Biotinylation of Recombinant Proteins Using BL21(λDE3)pBirA E. coli Cells
Share
A practical approach to producing site-specifically biotinylated recombinant proteins in E. coli cells
In vivo biotinylation is the attachment of biotin to a target protein inside a living cell during recombinant expression. This article explains how BL21(λDE3)pBirA E. coli cells support BirA-mediated biotinylation of AviTag-fused recombinant proteins.
Biotinylation enables proteins to be immobilized, captured, or detected through biotin's high-affinity interaction with streptavidin and avidin. Biotinylated proteins are widely used in applications including ELISA, surface plasmon resonance (SPR), biolayer interferometry (BLI), pull-down assays, flow cytometry, and protein interaction studies.
Other approaches for obtaining biotinylated recombinant proteins include chemical modification of purified proteins or enzymatic biotinylation after purification using the BirA biotin ligase. These approaches require careful optimization to achieve consistent labeling without compromising protein structure or biological activity.
Amid Biosciences' BL21(λDE3)pBirA Chemically Competent E. coli Cells are designed specifically for this purpose. By combining the protein expression capabilities of the BL21(DE3) host with an IPTG-inducible BirA biotin ligase expression system, this strain provides a convenient platform for producing AviTag-fused, biotinylated recombinant proteins directly in E. coli.

1. What Is In Vivo Biotinylation?
Biotin (vitamin B7) is a small molecule that binds to streptavidin and avidin with exceptionally high affinity. This interaction is widely exploited in molecular biology and biotechnology to capture, immobilize, and detect proteins.
Biotinylation is the enzymatic or chemical attachment of biotin to a protein.
For recombinant protein applications, site-specific biotinylation is particularly valuable. Unlike chemical biotinylation, which can modify multiple accessible lysine residues and produce heterogeneous labeling, enzymatic biotinylation allows biotin to be attached to a defined recognition sequence engineered into the target protein.
One of the most commonly used approaches relies on BirA biotin ligase, an enzyme naturally found in E. coli.
BirA recognizes a specific peptide sequence known as the biotin acceptor peptide (BAP), often referred to as AviTag.
The AviTag is a short, 15-amino-acid peptide that can be genetically fused to either the N- or C-terminus of a recombinant protein.
When the target protein is expressed in a bacterial cell containing functional BirA, the enzyme recognizes the AviTag and biotinylates the designated lysine residue within this sequence.
The result is a recombinant protein carrying a site-specific biotin modification that can subsequently be captured using streptavidin-based reagents.
2. How Does the BL21(λDE3)pBirA Expression System Work?
The BL21(λDE3)pBirA strain combines two complementary functions:
- BL21(λDE3): A widely used recombinant protein expression host carrying the λDE3 lysogen, which provides IPTG-inducible T7 RNA polymerase for expression from T7 promoter-driven vectors.
- pBirA plasmid: An additional plasmid encoding BirA biotin ligase under an IPTG-inducible expression system.
This arrangement allows researchers to express their target protein and provide the enzymatic machinery required for biotinylation within the same bacterial host.
The Expression and Biotinylation Mechanism
The workflow involves several coordinated steps.
Step 1. Construct an AviTag-fusion expression plasmid
The gene encoding the protein of interest is cloned into an appropriate bacterial expression vector with an AviTag sequence or other biotin acceptor peptide sequences recognized by E. coli BirA biotin ligase.
The AviTag can be positioned at the N-terminus or C-terminus, depending on the protein structure, functional requirements, and accessibility of the tag.
For example:
Target protein – AviTag – His-tag
or
His-tag-AviTag – Target protein
A His-tag can be included to facilitate downstream purification by immobilized metal affinity chromatography (IMAC).
Step 2. Transform BL21(λDE3)pBirA cells
The recombinant expression plasmid is introduced into BL21(λDE3)pBirA chemically competent E. coli cells.
The resulting bacterial cells contain two plasmids:
- The expression vector encoding the AviTag-fused target protein.
- The pBirA plasmid encoding biotin ligase.
The two plasmids are maintained using their respective antibiotic selection markers.
Step 3. Induce protein expression and BirA activity
Following bacterial cultivation, IPTG is added to induce expression.
The BL21(λDE3) system produces T7 RNA polymerase, which drives expression of the target protein from a T7 promoter. IPTG also induces BirA expression from the pBirA plasmid.
D-biotin is supplied to the culture as the substrate for the enzymatic reaction.
Step 4. Enzymatic biotinylation inside the bacterial cell
BirA recognizes the AviTag sequence on the newly synthesized target protein.
The enzyme activates biotin using ATP and transfers it to the specific lysine residue within the AviTag.
This results in site-specific biotinylation during intracellular protein production.
Step 5. Protein purification
Following expression, bacterial cells are harvested and processed using an appropriate protein purification protocol.
For His-tagged constructs, nickel- or cobalt-based affinity chromatography can be used to isolate the recombinant protein.
The purified protein can then be evaluated for expression level, purity, and biotinylation efficiency.
Overview of the BL21(λDE3)pBirA Workflow:
- Clone the target gene with an AviTag into an appropriate expression vector.
- Transform BL21(λDE3)pBirA competent cells.
- Select transformants using the appropriate antibiotics.
- Grow the bacterial culture and induce expression with IPTG.
- Supplement the culture with D-biotin.
- Allow protein expression and BirA-mediated biotinylation.
- Harvest cells and purify the recombinant protein.
- Evaluate protein purity and biotinylation efficiency.
The exact induction conditions should be optimized for each target protein. Expression level, protein solubility, folding, tag accessibility, and biotin availability can all influence the final result.
3. Why Use BL21(λDE3)pBirA Instead of Standard BL21(DE3)?
Standard BL21(DE3) cells are widely used for recombinant protein expression, particularly with pET expression vectors. However, they do not provide the additional BirA expression system required for convenient intracellular AviTag biotinylation.
Researchers using standard BL21(DE3) cells typically need to introduce BirA separately or perform an additional enzymatic biotinylation step after protein purification.
BL21(λDE3)pBirA addresses this limitation by providing the BirA expression machinery as part of the host system.
| Feature | Standard BL21(DE3) | BL21(λDE3)pBirA |
|---|---|---|
| T7 promoter-driven expression | Yes | Yes |
| Recombinant protein production | Yes | Yes |
| BirA expression plasmid | No | Yes |
| In vivo AviTag biotinylation | Requires additional BirA system | Supported |
| Biotin supplementation | Not specifically required | Required for the biotinylation workflow |
| Co-expression capability | Depends on expression constructs | Target protein and BirA |
Key Advantages of the BL21(λDE3)pBirA System
1. Site-specific biotinylation
BirA-mediated recognition of the AviTag enables biotin attachment at a defined position rather than random modification of accessible lysine residues.
This is particularly useful when protein orientation and consistent immobilization are important for downstream assays.
2. Combined protein expression and biotinylation
The target protein and BirA biotin ligase are expressed in the same bacterial host. This eliminates the need to introduce a separate BirA expression system for each production workflow.
3. Compatibility with commonly used expression vectors
The strain supports many T7 promoter-driven and E. coli promoter-driven expression constructs, including compatible pET and pTrc vectors.
4. Simplified downstream processing
In vivo biotinylation can reduce the number of post-expression processing steps compared with workflows requiring separate enzymatic labeling of purified proteins.
5. Flexible recombinant protein engineering
Researchers can introduce AviTag sequences into different protein constructs and use the same host platform to explore biotinylation of multiple targets.
4. Applications of In Vivo Biotinylated Proteins
Site-specifically biotinylated proteins are valuable reagents in many biochemical, biophysical, and cell-based research applications.
Surface Plasmon Resonance (SPR) and Biolayer Interferometry (BLI)
SPR and BLI are widely used to characterize molecular interactions, determine binding affinities, and measure association and dissociation kinetics.
Biotinylated proteins can be immobilized on streptavidin-coated sensor surfaces or biosensor tips.
Site-specific biotinylation offers an advantage over random chemical labeling because it provides a more controlled attachment position and can help reduce variability in protein orientation.
This is particularly important when immobilization occurs close to a protein's functional binding interface.
ELISA and Immunoassays
Biotinylated recombinant proteins can be used as capture or detection reagents in streptavidin-based ELISA formats.
Their strong interaction with streptavidin allows efficient immobilization on assay surfaces and supports sensitive detection workflows.
Protein-Protein Interaction Studies
Biotinylated proteins are frequently used in pull-down assays and other affinity-based methods to investigate protein-protein interactions.
A biotinylated bait protein can be immobilized on streptavidin-coated magnetic beads or agarose resins and used to capture interacting proteins from complex samples.
Flow Cytometry and Cell-Binding Assays
Biotinylated recombinant ligands, receptors, and other proteins can be coupled to fluorescent streptavidin conjugates for cell-binding experiments and flow cytometry.
This approach is particularly useful for studying receptor-ligand interactions and screening potential binding partners.
Protein Immobilization and Biosensor Development
The biotin-streptavidin interaction is widely used in biosensor development, protein arrays, and surface-based analytical systems.
The ability to produce recombinant proteins with a defined biotinylation site provides researchers with greater control over immobilization strategies.
5. Practical Considerations for Successful Biotinylation
Although the BL21(λDE3)pBirA system simplifies the production of biotinylated proteins, several experimental parameters should be considered.
AviTag accessibility
The AviTag must be accessible to BirA. Its position relative to the target protein can influence biotinylation efficiency. Both N-terminal and C-terminal fusion strategies may be worth evaluating.
Biotin concentration
D-biotin is required for the BirA-catalyzed reaction. Insufficient biotin availability can limit labeling efficiency. The appropriate concentration should be optimized for the expression system and target protein.
Expression conditions
High expression levels do not necessarily result in high biotinylation efficiency. Protein folding, solubility, and the availability of functional BirA can influence the final proportion of biotinylated protein.
Temperature, IPTG concentration, and induction time should be optimized for individual constructs.
Plasmid compatibility and selection
The pBirA plasmid must be maintained during cultivation. Appropriate antibiotic selection is required for both the BirA plasmid and the target expression vector.
Researchers should verify the resistance markers of their expression constructs before starting the experiment.
Verification of biotinylation
Protein purity alone does not establish biotinylation efficiency. We recommend independently evaluating biotin incorporation using an appropriate method, such as streptavidin-based Western blotting, streptavidin-HRP detection, or a quantitative biotinylation assay.
For demanding applications, the percentage of biotinylated protein should be determined before using the material in quantitative binding studies.
6. BL21(λDE3)pBirA Competent Cells from Amid Biosciences
Amid Biosciences provides BL21(λDE3)pBirA chemically competent E. coli cells for recombinant protein expression and in vivo biotinylation.
Our strain is designed to support BirA co-expression and production of AviTag-fused recombinant proteins using commonly employed bacterial expression vectors.
| Parameter | Specification |
|---|---|
| Strain | BL21(λDE3)pBirA |
| Cell type | Chemically competent E. coli |
| Transformation method | Heat shock |
| Transformation efficiency | >1 × 10⁴ CFU/µg pBR322 |
| BirA expression | IPTG-inducible |
| Compatible expression systems | T7 and E. coli promoter-driven vectors |
| Compatible vectors | Including pET and pTrc |
| Format | 10 × 0.1 mL |
| Storage | −80°C |
| Catalog number | BLB-201 |
Each product is supplied with a Certificate of Analysis (CoA). Quality control includes transformation efficiency validation, genotype verification, and contamination testing.
The product includes a transformation and induction protocol to help researchers establish their expression workflows.
Conclusion
In vivo biotinylation provides an efficient approach to producing site-specifically biotinylated recombinant proteins in E. coli.
By combining the BL21(DE3) protein expression platform with an IPTG-inducible BirA expression plasmid, BL21(λDE3)pBirA allows researchers to perform recombinant protein production and AviTag biotinylation within the same bacterial host.
For laboratories developing biotinylated ligands, receptors, enzymes, antibodies, and other recombinant proteins, this system offers a practical alternative to workflows requiring separate post-purification enzymatic labeling.
Amid Biosciences BL21(λDE3)pBirA Chemically Competent Cells are available for researchers looking to establish or expand their in vivo biotinylation capabilities.
Explore the product: BL21(λDE3)pBirA E. coli Cells for In Vivo Biotinylation
For technical questions about expression vectors, AviTag constructs, or biotinylation workflows, contact our scientific team at info@amidbiosciences.com.
For Research Use Only. Not for diagnostic or therapeutic use.